ICUI 71.85 Icu Medical $ICUI Hit a 52 week high of
Post# of 27
Posted On: 11/05/2014 11:49:16 PM
ICUI 71.85 Icu Medical $ICUI Hit a 52 week high of 72.24 Closing the day 11/05/14 at 71.85 +0.71 +1.00% With a day low of 71.26 and a total volume of 119,463.
ICUI Recent Posts: http://investorshangout.com/Icu-Medical-ICUI-54414/
ICUI Icu Medical Recent Headline News
Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), GWPH: 71.34 (-1.98), SPHS: 3.08 (-0.12)
Rockwell Medical (RMTI) Worth Watching: Stock Surges 21.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, as the company saw its shares surge over 21% on the day.
ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), GWPH: 71.34 (-1.98), RMTI: 9.18 (-1.45)
CVS Health Beats Q3 Earnings, Revenues; Narrows Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 1:00PM CST
CVS Health Corporation (CVS) ??? formerly known as CVS Caremark ??? reported third-quarter 2014 adjusted earnings per share (EPS) of $1.15.
BSX: 13.33 (+0.07), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), CVS: 87.50 (+2.03)
Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.33 (+0.07), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), HAE: 36.42 (+0.93)
14.1% Return Seen to Date on SmarTrend ICU Medical Call (ICUI)
Comtex SmarTrend(R) - Tue Nov 04, 11:13AM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 14.13% as of today's recent price of $70.99.
ICUI: 71.85 (+0.71)
Cardiovascular Systems (CSII) Jumps: Stock Rises 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:46AM CST
Cardiovascular Systems (CSII) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.85 (+0.71), CSII: 29.88 (-0.14), ABAX: 54.45 (+1.07), GWPH: 71.34 (-1.98)
Strength Seen in AtriCure (ATRC): Stock Gains 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:25AM CST
AtriCure (ATRC) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), GWPH: 71.34 (-1.98), ATRC: 16.67 (-0.30)
Merge Healthcare Q3 Revenues Top Estimates, Earnings Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:10PM CDT
Merge Healthcare Incorporated (MRGE) reported third-quarter 2014 adjusted net income per share of 4 cents.
BSX: 13.33 (+0.07), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), MRGE: 3.00 (+0.09)
Walgreens Banks on Alliance Boots Deal, Headwinds Persist - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:35PM CDT
On Oct 27, we issued an updated research report on Walgreen Co. (WAG).
ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), ALR: 40.20 (+0.13), WAG: 65.66 (+0.42)
ICU Medical Has Returned 13.3% Since SmarTrend Recommendation (ICUI)
Comtex SmarTrend(R) - Tue Oct 28, 9:59AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 13.26% as of today's recent price of $70.45.
ICUI: 71.85 (+0.71)
ICU Medical, Inc. Announces Time of Third Quarter 2014 Earnings Call
GlobeNewswire - Mon Oct 27, 3:10PM CDT
ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its third quarter 2014 earnings release conference call.
ICUI: 71.85 (+0.71)
Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 71.85 (+0.71), ZLTQ: 26.12 (-0.32), ABAX: 54.45 (+1.07), RMD: 51.45 (-0.36)
Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.85 (+0.71), ZLTQ: 26.12 (-0.32), ABAX: 54.45 (+1.07), CRDC: 0.96 (unch)
Zimmer Beats on Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:03PM CDT
Zimmer Holdings (ZMH) reported third-quarter 2014 adjusted earnings per share of $1.35.
ZMH: 110.99 (+1.78), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), ALR: 40.20 (+0.13)
Boston Scientific Earnings, Revenues in Line; View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 1:50PM CDT
Boston Scientific (BSX) reported adjusted EPS of 20 cents in the third quarter of 2014, 17.6% ahead of the year-ago adjusted number.
BSX: 13.33 (+0.07), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), ALR: 40.20 (+0.13)
Strength Seen in Cerus (CERS): Stock Gains 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 8:46AM CDT
Cerus (CERS) was a big mover last session, with shares rising over 6% on the day.
CERS: 3.92 (-0.17), ICUI: 71.85 (+0.71), ZLTQ: 26.12 (-0.32), ABAX: 54.45 (+1.07)
Mead Johnson Poised on Global Growth, R&D Initiatives - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 4:25PM CDT
On Oct 17, 2014, we initiated our coverage on Mead Johnson Nutrition Company (MJN), a global leader in pediatric nutrition, especially for infants and children.
ICUI: 71.85 (+0.71), MJN: 98.79 (+0.38), ABAX: 54.45 (+1.07), ALR: 40.20 (+0.13)
ICU Medical ConMed Stat2 Flow Controller Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed
PRWeb - Thu Oct 16, 2:30AM CDT
AttorneyOne.com, a recognized authority on law, updates the website daily regarding all the latest information from the FDA on Stat2 Flow Controller.
ICUI: 71.85 (+0.71)
Medtronic Reveals Restructuring Plan post Covidien Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:10PM CDT
Medtronic Inc. (MDT) recently detailed its senior management team for the combined entity post the impending Covidien acquisition and restructured its business segments.
ICUI: 71.85 (+0.71), ZLTQ: 26.12 (-0.32), MDT: 68.70 (+0.77), COV: 93.32 (+1.29)
ICUI Recent Posts: http://investorshangout.com/Icu-Medical-ICUI-54414/
ICUI Icu Medical Recent Headline News
Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), GWPH: 71.34 (-1.98), SPHS: 3.08 (-0.12)
Rockwell Medical (RMTI) Worth Watching: Stock Surges 21.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, as the company saw its shares surge over 21% on the day.
ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), GWPH: 71.34 (-1.98), RMTI: 9.18 (-1.45)
CVS Health Beats Q3 Earnings, Revenues; Narrows Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 1:00PM CST
CVS Health Corporation (CVS) ??? formerly known as CVS Caremark ??? reported third-quarter 2014 adjusted earnings per share (EPS) of $1.15.
BSX: 13.33 (+0.07), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), CVS: 87.50 (+2.03)
Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.33 (+0.07), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), HAE: 36.42 (+0.93)
14.1% Return Seen to Date on SmarTrend ICU Medical Call (ICUI)
Comtex SmarTrend(R) - Tue Nov 04, 11:13AM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 14.13% as of today's recent price of $70.99.
ICUI: 71.85 (+0.71)
Cardiovascular Systems (CSII) Jumps: Stock Rises 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:46AM CST
Cardiovascular Systems (CSII) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.85 (+0.71), CSII: 29.88 (-0.14), ABAX: 54.45 (+1.07), GWPH: 71.34 (-1.98)
Strength Seen in AtriCure (ATRC): Stock Gains 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:25AM CST
AtriCure (ATRC) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), GWPH: 71.34 (-1.98), ATRC: 16.67 (-0.30)
Merge Healthcare Q3 Revenues Top Estimates, Earnings Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:10PM CDT
Merge Healthcare Incorporated (MRGE) reported third-quarter 2014 adjusted net income per share of 4 cents.
BSX: 13.33 (+0.07), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), MRGE: 3.00 (+0.09)
Walgreens Banks on Alliance Boots Deal, Headwinds Persist - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:35PM CDT
On Oct 27, we issued an updated research report on Walgreen Co. (WAG).
ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), ALR: 40.20 (+0.13), WAG: 65.66 (+0.42)
ICU Medical Has Returned 13.3% Since SmarTrend Recommendation (ICUI)
Comtex SmarTrend(R) - Tue Oct 28, 9:59AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 13.26% as of today's recent price of $70.45.
ICUI: 71.85 (+0.71)
ICU Medical, Inc. Announces Time of Third Quarter 2014 Earnings Call
GlobeNewswire - Mon Oct 27, 3:10PM CDT
ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its third quarter 2014 earnings release conference call.
ICUI: 71.85 (+0.71)
Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 71.85 (+0.71), ZLTQ: 26.12 (-0.32), ABAX: 54.45 (+1.07), RMD: 51.45 (-0.36)
Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.85 (+0.71), ZLTQ: 26.12 (-0.32), ABAX: 54.45 (+1.07), CRDC: 0.96 (unch)
Zimmer Beats on Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:03PM CDT
Zimmer Holdings (ZMH) reported third-quarter 2014 adjusted earnings per share of $1.35.
ZMH: 110.99 (+1.78), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), ALR: 40.20 (+0.13)
Boston Scientific Earnings, Revenues in Line; View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 1:50PM CDT
Boston Scientific (BSX) reported adjusted EPS of 20 cents in the third quarter of 2014, 17.6% ahead of the year-ago adjusted number.
BSX: 13.33 (+0.07), ICUI: 71.85 (+0.71), ABAX: 54.45 (+1.07), ALR: 40.20 (+0.13)
Strength Seen in Cerus (CERS): Stock Gains 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 8:46AM CDT
Cerus (CERS) was a big mover last session, with shares rising over 6% on the day.
CERS: 3.92 (-0.17), ICUI: 71.85 (+0.71), ZLTQ: 26.12 (-0.32), ABAX: 54.45 (+1.07)
Mead Johnson Poised on Global Growth, R&D Initiatives - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 4:25PM CDT
On Oct 17, 2014, we initiated our coverage on Mead Johnson Nutrition Company (MJN), a global leader in pediatric nutrition, especially for infants and children.
ICUI: 71.85 (+0.71), MJN: 98.79 (+0.38), ABAX: 54.45 (+1.07), ALR: 40.20 (+0.13)
ICU Medical ConMed Stat2 Flow Controller Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed
PRWeb - Thu Oct 16, 2:30AM CDT
AttorneyOne.com, a recognized authority on law, updates the website daily regarding all the latest information from the FDA on Stat2 Flow Controller.
ICUI: 71.85 (+0.71)
Medtronic Reveals Restructuring Plan post Covidien Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:10PM CDT
Medtronic Inc. (MDT) recently detailed its senior management team for the combined entity post the impending Covidien acquisition and restructured its business segments.
ICUI: 71.85 (+0.71), ZLTQ: 26.12 (-0.32), MDT: 68.70 (+0.77), COV: 93.32 (+1.29)
(0)
(0)ICU Medical Inc. (ICUI) Stock Research Links
Scroll down for more posts ▼